Highly active antiretroviral treatment containing efavirenz or nevirapine and related toxicity in the TREAT Asia HIV Observational Database

J Acquir Immune Defic Syndr. 2006 Dec 1;43(4):501-3. doi: 10.1097/01.qai.0000243109.33759.81.
No abstract available

Publication types

  • Letter
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alkynes
  • Anti-HIV Agents / adverse effects
  • Antiretroviral Therapy, Highly Active / adverse effects*
  • Benzoxazines
  • Chemical and Drug Induced Liver Injury*
  • Cyclopropanes
  • Drug Therapy, Combination
  • Exanthema / chemically induced*
  • HIV Infections / drug therapy*
  • HIV Infections / virology
  • HIV-1
  • Humans
  • Nevirapine / adverse effects*
  • Oxazines / adverse effects*
  • Reverse Transcriptase Inhibitors / adverse effects

Substances

  • Alkynes
  • Anti-HIV Agents
  • Benzoxazines
  • Cyclopropanes
  • Oxazines
  • Reverse Transcriptase Inhibitors
  • Nevirapine
  • efavirenz